New research from Michigan Medicine could help improve treatment and outcomes for patients with triple-negative breast cancer brain metastases. Nathan Merrill, Ph.D., assistant professor of hematology/oncology at Michigan Medicine and corresponding author on a new paper, shares insights from his findings and approach.
